谷歌浏览器插件
订阅小程序
在清言上使用

A Case of Olmesartan-induced Enteropathy

Hisashi Matsumoto, Yoshikazu Tsuzuki, Keigo Ashitani, Hideki Ogo, Takaya Ichimura, Atsushi Sasaki, Hidetomo Nakamoto, Hiroyuki Imaeda

Progress of digestive endoscopy/Prog dig endosc(2020)

引用 0|浏览32
暂无评分
摘要
Olmesartan has recently been reported as a cause of drug-induced enteropathy characterized by chronic diarrhoea and duodenal mucosal atrophy demonstrating sprue-like enteropathy. 82-year-old, male presented to our hospital because of chronic severe watery diarrhea without abdominal pain or fever. Blood examination showed mild anemia (Hb 11.2 mg/dl). Abdominal contrast-enhanced computed tomography showed mucosal edema in the large intestine. Esophagogastroduodenoscopy showed no villous atrophy in the duodenum with the possibility of pyloric gastrectomy, however, colonoscopy showed villous flattering in the terminal ileum and edematous changes in sigmoid colon. Histopathologic examination in biopsy samples from the terminal ileum and sigmoid colon showed interstitial lymphocytic infiltration. He was treated with olmesartan for hypertension at least two years before the onset of symptoms. In addition, watery diarrhea improved soon after discontinuation of olmesartan. Therefore, he was diagnosed as olmesartan-induced enteropathy. Its pathogenesis remains unclear; however, olmesartan-induced enteropathy must be included in the differential diagnosis for patients with chronic diarrhea after the intake of olmesartan.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要